Kronos Bio, Inc. (KRON)

Kronos Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	66.35	78	200.3	250.04	32.57
Short-Term Investments	108.67	162.21	141.24	165.05	59.61
Cash & Cash Equivalents	175.02	240.21	341.54	415.09	92.18
Cash Growth	-27.14%	-29.67%	-17.72%	350.28%	801.47%
Other Current Assets	3.76	4.08	6.02	4.71	1.12
Total Current Assets	178.78	244.29	347.55	419.8	93.3
Property, Plant & Equipment	29.91	37.69	41.78	40.97	4.19
Long-Term Investments	1.99	9.76	0	49	4.76
Other Long-Term Assets	2.6	3.19	2.14	2.19	0.43
Total Long-Term Assets	34.5	50.65	43.92	92.16	9.38
Total Assets	213.28	294.94	391.48	511.96	102.69
Accounts Payable	0.88	5.05	1	4.55	1.51
Deferred Revenue	13.71	0	0	0	0
Current Debt	2.89	2.35	2.11	0.94	0.29
Other Current Liabilities	7.21	14.09	10.52	7.37	0.91
Total Current Liabilities	24.7	21.49	13.63	12.86	2.7
Long-Term Debt	25.38	28.74	31.65	31.12	0.21
Other Long-Term Liabilities	4.13	0.21	1.1	2.47	0.07
Total Long-Term Liabilities	29.51	28.95	32.75	33.59	0.29
Total Liabilities	54.2	50.44	46.38	46.45	2.98
Total Debt	28.27	31.09	33.76	32.06	0.5
Debt Growth	-9.07%	-7.91%	5.32%	6363.10%	-33.06%
Retained Earnings	-508.86	-396.19	-262.98	-111.91	-23.46
Comprehensive Income	0.02	-0.79	-0.04	-0.02	-0.02
Shareholders' Equity	159.08	244.5	345.1	465.52	-23.2
Net Cash / Debt	146.75	209.12	307.77	383.03	91.69
Net Cash / Debt Growth	-29.82%	-32.05%	-19.65%	317.75%	866.66%
Net Cash Per Share	2.54	3.72	5.62	23.53	17.37
Working Capital	154.08	222.81	333.93	406.95	90.61
Book Value Per Share	2.75	4.35	6.30	28.60	-4.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).